Dates:
, MAP kinase, or ion channel signaling, however, RGS proteins that bind Ga12/13 (12,13) and Gas (14) have also recently been identified. There is strong evidence implicating RGS proteins in the subsecond kinetics of G i -and G o -mediated ion channel activation and deactivation in neurons (15,16). More recently, the conserved RGS protein domain has been found to serve as a multifunctional protein adapter which can recruit many effectors or regulators to the vicinity of activated G proteins (for reviews see Refs 6,7,17). Notable examples include P115rhoGEF (12), the A kinase anchoring protein d-AKAP2 (18) and GRK2 (19).
One other intriguing aspect of RGS proteins is that they undergo rather profound regulation of expression by signal transduction events. This makes them uniquely well-suited to play a role in the cellular changes that underlie tolerance and/or dependence that are the hallmarks of drugs of abuse. 
CNS vs. peripheral tissues). The combination of an RGS
inhibitor with an opioid agonist would permit lower doses of opioid to be used, which might reduce tolerance and may also enhance signaling in selected brain regions if the RGS proteins important in those regions could be targeted by an inhibitor. Two preliminary reports have described RGS inhibitor peptides with micromolar potency (32, 33) . Further developments in this area are eagerly awaited.
Studies with the RGS-insensitive Ga subunits should provide a broad-brush view of RGS actions at a particular Ga subunit. A more targeted approach to deciding which RGS protein is mediating a particular function is also required. Ribozymes are unique RNA enzymes that can recognize and cleave other RNA molecules in a sequencespecific fashion (34) . They were initially used to inhibit gene expression in HIV virus (35) and cancer (36) . Compared with the antisense oligos, ribozymes offer significant advantages: (i) they operate as site-specific ribonucleases, resulting in catalytical cleavage of the target mRNAs; (ii); they are more stringent than antisense oligos in binding mRNA targets; (iii) controls for ribozyme activity can be made by substituting nucleotides in the catalytic core to produce an inactive ribozyme (37) . Among the several types of ribozymes, the hammerhead ribozymes are the most extensively characterized with enhanced catalytic turnover and stability (38) . They cleave 3¢ to a ÔGUCÕ sequence motif in the target mRNA (38) . Wang et al. (24) recently demonstrated that chemically synthesized ribozymes targeted against specific RGS proteins can be used to Ôknock-downÕ their expression in vascular smooth muscle cells. Interestingly, the RGS3-ribozyme selectively enhanced M3 muscarinic responses, whereas the RGS5-ribozyme selectively enhanced angiotensin II responses. Using the related antisense oligodeoxynucleotide approach, Garzon et al. (39) showed that an RGS9 antisense construct injected i.c.v.
produced an enhanced opioid analgesic effect with morphine and beta-endorphin, whereas an RGS2 antisense reduced the opioid effects. In contrast, Potenza et al. (40) found that overexpression of RGS2 inhibited opioid responses in a melanophore response system -an effect 
